China approves Synopsys’ $35 bln Ansys acquisition

China's State Administration for Market Regulation (SAMR) has granted conditional approval for Synopsys's $35 billion acquisition of Ansys, removing the final major regulatory obstacle after clearances from the U.S., EU, and UK. This approval, which includes stipulations regarding Synopsys's contracts with Chinese clients, reflects improving U.S.-China trade relations marked by recent reciprocal easing of export controls. The clearance paves the way for Synopsys to consolidate its market dominance in chip-design software, contributing to recent rallies in its shares.

Analysis

Synopsys (NASDAQ:SNPS) has secured the final regulatory clearance for its $35 billion acquisition of Ansys (NASDAQ:ANSS) after receiving conditional approval from China's State Administration for Market Regulation (SAMR). This removes the last significant obstacle to the merger, which had already been approved by authorities in the U.S., EU, and UK. The approval, however, is contingent upon Synopsys maintaining its existing contracts and renewal availability for Chinese clients, a condition that secures a key market but also embeds ongoing regulatory oversight. This development occurs within a broader context of improving U.S.-China trade relations, evidenced by a recent reciprocal easing of export controls on chip-design software from the U.S. and rare earths from China. For Synopsys, the green light paves the way to consolidate its market leadership in the critical chip-design software industry, a factor that has contributed to a recent rally in its share price.

Key Decisions for Investors

• With the final regulatory hurdle from China now cleared, the probability of the Synopsys-Ansys deal closing has significantly increased, which should lead to a narrowing of the merger arbitrage spread.
• Investors in Synopsys should consider this a major strategic positive that solidifies long-term market dominance, while also noting the condition to service Chinese clients secures revenue but maintains exposure to future U.S.-China trade policy shifts.
• The approval signals a potential thaw in the regulatory environment for cross-border tech M&A, suggesting investors may need to reassess the geopolitical risk premium applied to other U.S. technology firms with significant Chinese market operations.